MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER
Marpai (OTCQX: MRAI), a healthcare technology and Third-Party Administration (TPA) services provider, has appointed Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. Scrip brings extensive experience in scaling private equity and venture capital-owned companies, with expertise in healthcare consumer services, employers, providers, and payor markets.
The strategic hire aims to accelerate Marpai's profitable growth and enhance operational excellence. CEO Damien Lamendola emphasized that Scrip's appointment is crucial for the company's journey towards sustainable growth, citing his proven track record in complex healthcare environments and deep understanding of the TPA landscape.
Marpai (OTCQX: MRAI), azienda tecnologica nel settore sanitario e fornitore di servizi di Amministrazione Terza (TPA), ha nominato Dallas Scrip Chief Operating Officer (COO) e Presidente di MarpaiRx. Scrip vanta una vasta esperienza nella crescita di aziende di proprietà di private equity e venture capital, con competenze nei servizi sanitari al consumatore, datori di lavoro, fornitori e mercati assicurativi.
Questa nomina strategica mira ad accelerare la crescita redditizia di Marpai e a migliorare l'eccellenza operativa. Il CEO Damien Lamendola ha sottolineato che la scelta di Scrip è fondamentale per il percorso dell'azienda verso una crescita sostenibile, evidenziando il suo comprovato successo in ambienti sanitari complessi e la profonda conoscenza del settore TPA.
Marpai (OTCQX: MRAI), una empresa de tecnología sanitaria y proveedora de servicios de Administración de Terceros (TPA), ha nombrado a Dallas Scrip como Director de Operaciones (COO) y Presidente de MarpaiRx. Scrip aporta una amplia experiencia en la expansión de compañías propiedad de capital privado y de riesgo, con especialización en servicios de salud para consumidores, empleadores, proveedores y mercados de aseguradoras.
Esta contratación estratégica busca acelerar el crecimiento rentable de Marpai y mejorar la excelencia operativa. El CEO Damien Lamendola destacó que el nombramiento de Scrip es clave para el camino hacia un crecimiento sostenible de la empresa, resaltando su historial probado en entornos complejos de salud y su profundo conocimiento del sector TPA.
Marpai (OTCQX: MRAI)는 헬스케어 기술 및 제3자 관리(TPA) 서비스 제공업체로서 Dallas Scrip을 최고운영책임자(COO) 겸 MarpaiRx 사장으로 임명했습니다. Scrip은 사모펀드 및 벤처캐피털 소유 기업의 확장에 풍부한 경험을 갖추고 있으며, 헬스케어 소비자 서비스, 고용주, 제공자, 보험사 시장에 대한 전문성을 보유하고 있습니다.
이번 전략적 영입은 Marpai의 수익성 있는 성장을 가속화하고 운영 우수성을 강화하는 것을 목표로 합니다. CEO Damien Lamendola는 복잡한 헬스케어 환경에서의 입증된 실적과 TPA 분야에 대한 깊은 이해를 바탕으로 Scrip의 임명이 지속 가능한 성장 여정에 매우 중요하다고 강조했습니다.
Marpai (OTCQX: MRAI), fournisseur de technologies de santé et de services d'administration tierce (TPA), a nommé Dallas Scrip en tant que Directeur des Opérations (COO) et Président de MarpaiRx. Scrip possède une vaste expérience dans le développement d'entreprises détenues par des fonds de capital-investissement et de capital-risque, avec une expertise dans les services de santé aux consommateurs, les employeurs, les prestataires et les marchés des payeurs.
Cette embauche stratégique vise à accélérer la croissance rentable de Marpai et à améliorer l'excellence opérationnelle. Le PDG Damien Lamendola a souligné que la nomination de Scrip est essentielle pour le parcours de l'entreprise vers une croissance durable, citant son parcours éprouvé dans des environnements de santé complexes et sa compréhension approfondie du secteur TPA.
Marpai (OTCQX: MRAI), ein Anbieter von Gesundheitstechnologie und Third-Party-Administration (TPA)-Dienstleistungen, hat Dallas Scrip zum Chief Operating Officer (COO) und Präsidenten von MarpaiRx ernannt. Scrip bringt umfassende Erfahrung im Ausbau von Unternehmen im Besitz von Private-Equity- und Venture-Capital-Gesellschaften mit, mit Fachkenntnissen in den Bereichen Gesundheitsdienstleistungen für Verbraucher, Arbeitgeber, Anbieter und Kostenträger.
Die strategische Einstellung zielt darauf ab, das profitable Wachstum von Marpai zu beschleunigen und die operative Exzellenz zu verbessern. CEO Damien Lamendola betonte, dass Scrips Ernennung entscheidend für den Weg des Unternehmens zu nachhaltigem Wachstum sei und verwies auf seine nachgewiesene Erfolgsbilanz in komplexen Gesundheitsumgebungen sowie sein tiefes Verständnis der TPA-Landschaft.
- Strategic hire of experienced COO with proven track record in scaling healthcare companies
- New leadership addition focused on driving profitable growth
- Appointment brings expertise in TPA landscape and high-performance team building
- None.
Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment
Prior to joining Marpai, Mr. Scrip demonstrated significant success in startup, early-stage, and growth situations, scaling private equity and venture capital-owned companies. His expertise spans servicing healthcare consumers, employers, providers, and payor markets, with a strong foundation in sales and business development. Scrip is known for his process-oriented approach, identifying market needs, and strategically transforming companies through organic growth initiatives.
"We believe that the addition of
About Marpai, Inc.
Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the
Forward-Looking Statement Disclaimer
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses its belief that the addition of Mr. Scrip to its leadership team is a pivotal step in Marpai's journey towards sustainable and profitable high growth. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.
More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.
View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-hires-dallas-scrip-as-chief-operating-officer-302453643.html
SOURCE Marpai
FAQ
Who is Dallas Scrip and what is his new role at Marpai (MRAI)?
What is Marpai's (MRAI) strategic goal with the new COO appointment?
What experience does Dallas Scrip bring to Marpai (MRAI)?
Who is the current CEO of Marpai (MRAI)?
